1. 2020
  2. Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations

    van den Boogert, M. A. W., Crunelle, C. L., Ali, L., Larsen, L. E., Kuil, S. D., Levels, J. H. M., Schimmel, A. W. M., Konstantopoulou, V., Guerin, M., Kuivenhoven, J. A., Dallinga-Thie, G. M., Stroes, E. S. G., Lefeber, D. J. & Holleboom, A. G., 1 May 2020, In: Journal of inherited metabolic disease. 43, 3, p. 611-617 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Niet-alcoholische leververvetting Een lijvige epidemie

    Tushuizen, M. E., Holleboom, A. G., Koot, P., Blokzijl, H., van Mil, S. W. C. & Koek, G. H., 2020, In: Nederlands tijdschrift voor geneeskunde. 164, 10, D4096.

    Research output: Contribution to journalArticleProfessional

  4. The role of the gut microbiome and exercise in non-alcoholic fatty liver disease

    Houttu, V., Boulund, U., Grefhorst, A., Soeters, M. R., Pinto-Sietsma, S-J., Nieuwdorp, M. & Holleboom, A. G., 2020, In: Therapeutic advances in gastroenterology. 13

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. 2019
  6. The P274S Mutation of Lecithin-Cholesterol Acyltransferase (LCAT) and Its Clinical Manifestations in a Large Kindred

    Fountoulakis, N., Lioudaki, E., Lygerou, D., Dermitzaki, E-K., Papakitsou, I., Kounali, V., Holleboom, A. G., Stratigis, S., Belogianni, C., Syngelaki, P., Stratakis, S., Evangeliou, A., Gakiopoulou, H., Kuivenhoven, J. A., Wevers, R., Dafnis, E. & Stylianou, K., Oct 2019, In: American journal of kidney diseases. 74, 4, p. 510-522

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Moving Targets: Recent Advances in Lipid-Lowering Therapies

    Larsen, L. E., Stoekenbroek, R. M., Kastelein, J. J. P. & Holleboom, A. G., Mar 2019, In: Arteriosclerosis, thrombosis, and vascular biology. 39, 3, p. 349-359 11 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?

    Stols-Gonçalves, D., Hovingh, G. K., Nieuwdorp, M. & Holleboom, A. G., 2019, In: Trends in endocrinology and metabolism: TEM.

    Research output: Contribution to journalReview articleAcademicpeer-review

  9. N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression

    van den Boogert, M. A. W., Larsen, L. E., Ali, L., Kuil, S. D., Chong, P. L. W., Loregger, A., Kroon, J., Schnitzler, J. G., Schimmel, A. W. M., Peter, J., Levels, J. H. M., Steenbergen, G., Morava, E., Dallinga-Thie, G. M., Wevers, R. A., Kuivenhoven, J. A., Hand, N. J., Zelcer, N., Rader, D. J., Stroes, E. S. G., & 2 othersLefeber, D. J. & Holleboom, A. G., 2019, In: Circulation. 140, 4, p. 280-292

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease

    Koopman, N., Molinaro, A., Nieuwdorp, M. & Holleboom, A. G., 2019, In: Alimentary pharmacology & therapeutics. 50, 6, p. 628-639

    Research output: Contribution to journalReview articleAcademicpeer-review

  11. 2018
  12. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis

    Oldoni, F., Baldassarre, D., Castelnuovo, S., Ossoli, A., Amato, M., van Capelleveen, J., Hovingh, G. K., de Groot, E., Bochem, A., Simonelli, S., Barbieri, S., Veglia, F., Franceschini, G., Kuivenhoven, J. A., Holleboom, A. G. & Calabresi, L., 2018, In: Circulation. 138, 10, p. 1000-1007

    Research output: Contribution to journalArticleAcademicpeer-review

  13. 2017
  14. New insights into the role of glycosylation in lipoprotein metabolism

    van den Boogert, M. A. W., Rader, D. J. & Holleboom, A. G., 2017, In: Current opinion in lipidology. 28, 6, p. 502-506

    Research output: Contribution to journalReview articleAcademicpeer-review

ID: 5136148